The Justice Department’s Antitrust Division has filed a federal lawsuit against NewYork-Presbyterian, the largest and most powerful hospital system in New York City, alleging that the health system uses anticompetitive contract practices to eliminate patient choice and prevent lower-cost healthcare options. Filed in March 2026 in the U.S. District Court for the Southern District of New York, the lawsuit accuses NewYork-Presbyterian of violating Section 1 of the Sherman Act through “all-or-nothing” contracting arrangements that force insurance companies to include the hospital system in their plans on the most favorable terms or not at all.
This case represents a significant escalation in the federal government’s effort to combat healthcare consolidation and pricing power in hospital markets. The core allegation is straightforward: NewYork-Presbyterian uses its dominant position in the NYC healthcare market to impose contract restrictions that prevent insurance companies from offering patients lower copays when they choose care at competing hospitals. For example, if an insurance company negotiates better rates with a rival hospital system to offer patients savings, NewYork-Presbyterian’s contracts prohibit the insurer from passing those savings to patients. This article explains what the lawsuit alleges, how these practices affect consumers and the healthcare market, what legal process lies ahead, and how this case fits into a broader Department of Justice campaign against hospital consolidation and anticompetitive conduct.
Table of Contents
- What Exactly Is NewYork-Presbyterian Accused of Doing?
- How Do These Contracts Prevent Lower-Cost Healthcare Options?
- How Does This Affect Patients and Insurance Coverage?
- What Happens Next in the Legal Process?
- What Does This Mean for Healthcare Markets?
- How Does NewYork-Presbyterian’s Market Position Matter?
- What Might Change If the Government Wins?
What Exactly Is NewYork-Presbyterian Accused of Doing?
The Justice department alleges that NewYork-Presbyterian uses three specific anticompetitive tactics to maintain and expand its market power. First, the hospital system imposes “all-or-nothing” contract restrictions that prevent insurance companies from offering plans that exclude NewYork-Presbyterian entirely. This means an insurer cannot create a lower-cost health plan by negotiating with competing hospitals if that plan would leave out NewYork-Presbyterian. Second, NewYork-Presbyterian requires that payors place the hospital system in the most favored tier of their insurance plans—the tier with the lowest patient out-of-pocket costs. Third, and perhaps most directly affecting patients, NewYork-Presbyterian forbids payors from offering lower copays when patients choose care at competing hospitals.
In practical terms, if a patient goes to a rival hospital system for the same procedure, they cannot benefit from any discounted rates that hospital negotiated with their insurance company. The lawsuit emphasizes that these practices are particularly harmful because NewYork-Presbyterian is not just a large hospital system—it is the largest and most powerful hospital network in New York City, operating 8 hospitals and numerous outpatient facilities across the region. This dominant position gives the health system use that smaller competitors simply do not have. Insurance companies negotiating in the New York healthcare market often feel compelled to accept NewYork-Presbyterian’s terms because excluding the hospital system from their networks would make their plans unattractive to consumers, employers, and healthcare brokers. The system knows this, and the government alleges it uses this power to prevent competitive pricing and limit patient access to lower-cost alternatives.
How Do These Contracts Prevent Lower-Cost Healthcare Options?
To understand the harm the government alleges, consider how healthcare pricing normally works in competitive markets. When multiple hospital systems operate in a region, insurance companies can negotiate different rates with each system based on quality, efficiency, and service. If one hospital system operates more efficiently and offers better rates, the insurance company can pass those savings to patients through lower premiums or copays. This competition incentivizes hospitals to operate efficiently and offer good value. However, when a dominant hospital system imposes the restrictions NewYork-Presbyterian allegedly uses, it breaks this competitive dynamic. The “all-or-nothing” restriction is particularly restrictive because it operates as a take-it-or-leave-it ultimatum. An insurance company cannot create an innovative health plan that lowers costs by strategically using competing hospitals for certain services where those competitors excel. For example, if a rival hospital system has a superior orthopedic surgery program at better rates, the insurance company cannot offer a tiered plan that steers knee replacement patients to that hospital and offers them lower copays for choosing it.
Instead, NewYork-Presbyterian’s contracts prevent this. The hospital system’s requirement to be in the “most favored tier” with the lowest copays means the insurer cannot give patients financial incentives to seek care at lower-cost alternatives. This removes a key market mechanism that normally drives healthcare costs down: patient choice incentivized by price. However, NewYork-Presbyterian disputes these allegations entirely. The hospital system has stated that it believes the lawsuit is without merit. The case will require the court to examine detailed contracts, pricing data, and the competitive effects of these practices—matters that the hospital system may view differently. Healthcare contracting is complex, and hospitals argue that their contract terms often reflect the costs of maintaining network adequacy and service quality. The court will need to determine whether NewYork-Presbyterian’s market power is so significant that these contract terms constitute anticompetitive conduct, or whether they are reasonable business practices in healthcare markets.
How Does This Affect Patients and Insurance Coverage?
While these legal and contractual issues may seem abstract, they directly impact patients’ ability to access affordable healthcare and their freedom to choose where they receive care. When a dominant hospital system prevents insurance companies from offering lower-cost alternatives, patients pay the price—literally. Higher healthcare costs translate into higher insurance premiums for employers and workers, higher copays and deductibles for patients, and reduced incentive for patients to shop for lower-cost providers even when options exist. The practical impact varies depending on the patient’s situation. A patient covered by an insurance plan that includes NewYork-Presbyterian will likely find the hospital system available to them, but may face high copays or coinsurance. If that patient wants to seek care at a rival hospital system that negotiated lower rates with the insurance company, they typically cannot benefit from those lower rates—they face the same cost-sharing as they would at NewYork-Presbyterian.
This removes a key way that healthcare markets normally function: price competition that benefits consumers. Additionally, the “all-or-nothing” restriction means that insurance companies cannot create specialty networks or lower-cost options that exclude NewYork-Presbyterian, even in situations where the hospital system may not be necessary for adequate care. For employers and health plan administrators, these contract terms reduce their negotiating use. Instead of having genuine choices about which hospital systems to include in their networks, they face take-it-or-leave-it terms from the dominant provider. This reduces their ability to shop for better rates or to structure networks based on value and quality. The Department of Justice argues that this harms competition and consumers, which is precisely why federal antitrust law exists—to ensure that markets remain competitive and that dominant firms do not abuse their power to prevent rivals from competing.
What Happens Next in the Legal Process?
This lawsuit was filed by the Justice Department’s Antitrust Division together with the U.S. Attorney’s Office for the Southern District of New York. The case will proceed in the U.S. District Court for the Southern District of New York, which handles federal antitrust cases and has experience with healthcare antitrust matters. The lawsuit seeks to prevent NewYork-Presbyterian from continuing these practices and may seek damages or other remedies, though the specific relief requested will be clarified as the case develops.
Typically, healthcare antitrust cases proceed through several stages: initial pleadings and motions (which may include NewYork-Presbyterian’s motion to dismiss the complaint), discovery (where both sides exchange documents and conduct depositions), and eventually trial if the case is not settled. These cases often take years to resolve. The government will need to prove that NewYork-Presbyterian’s practices harm competition and consumers. NewYork-Presbyterian will argue that its contract terms are reasonable and do not violate the Sherman Act. One important note: antitrust lawsuits can sometimes result in settlement agreements where the defendant agrees to stop certain practices without admitting wrongdoing. Whether this case settles or goes to trial, the outcome could significantly reshape hospital contracting in the New York City healthcare market.
What Does This Mean for Healthcare Markets?
This lawsuit is not isolated. It is part of a broader Department of Justice campaign to combat anticompetitive conduct in healthcare markets. Earlier in 2026, the DOJ sued OhioHealth on similar grounds—alleging that the health system uses its market power to impose contract restrictions that prevent patients from accessing lower-cost competitors. These cases reflect a shift in how federal enforcers view healthcare consolidation and market power. The Acting head of the DOJ Antitrust Division has emphasized that lower prices in healthcare are “exactly the kind of kitchen-table priority we should be pursuing.” This framing reflects a focus on consumer welfare and real-world impact: healthcare costs directly affect families’ budgets and financial security.
The broader implication is that hospitals with dominant market positions may find their contracting practices subject to increased legal scrutiny. If the DOJ prevails against NewYork-Presbyterian, it could establish precedent that other dominant hospital systems cannot impose similar all-or-nothing restrictions. This could encourage more competitive pricing and innovation in healthcare contracting. However, hospitals argue that their contracting practices often reflect legitimate business concerns, such as ensuring network adequacy and managing patient volume. Some argue that aggressive antitrust enforcement could reduce hospitals’ negotiating use, potentially affecting their ability to invest in services and infrastructure. The tension between these viewpoints will play out in courts across the country.
How Does NewYork-Presbyterian’s Market Position Matter?
The fact that NewYork-Presbyterian is described as “the largest and most powerful hospital system in New York City” is central to the government’s case. In antitrust law, market power matters enormously. A small hospital system using the same contracting terms might not violate antitrust law because it lacks the market power to foreclose competition. But NewYork-Presbyterian operates 8 hospitals and many outpatient facilities across the NYC area—a dominant position in one of the nation’s largest metropolitan healthcare markets.
This scale means that insurance companies, employers, and patients may have no realistic alternative but to include NewYork-Presbyterian in their networks. Because of this dominance, NewYork-Presbyterian’s contract terms effectively set the market standard. Other hospital systems must compete against those terms, and insurance companies cannot easily replace NewYork-Presbyterian with alternatives. The government’s position is that this market power allows NewYork-Presbyterian to impose restrictions it could not impose if it were a smaller, less essential hospital system. The lawsuit essentially argues that with great market power comes great responsibility—and that dominant firms cannot use that power to prevent competitors from offering lower-cost alternatives.
What Might Change If the Government Wins?
If the Department of Justice prevails, NewYork-Presbyterian would likely be required to remove or modify the contract restrictions alleged in the lawsuit. This could allow insurance companies to exclude NewYork-Presbyterian from some plans, to negotiate different tier placements for different services, and to offer patients financial incentives to seek care at competing hospitals when appropriate. The practical effect would be increased competition and potentially lower prices for healthcare services in New York City.
However, the broader healthcare landscape will continue to evolve. Even if NewYork-Presbyterian loses, other dominant hospital systems face similar scrutiny. The healthcare industry’s ongoing consolidation trend—where larger systems acquire smaller hospitals and practices—remains a concern for antitrust enforcers. Future cases and regulatory action may further reshape how hospitals and health plans interact, how patients choose providers, and how healthcare is priced and accessed in America.